17h
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback